Advanced Solid Malignancies, Malignant Lymphoma
Conditions
Interventions
investigational material(s)
Generic name etc : AZD1208
INN of investigational material :
Therapeutic category code : 429 Other antitumor agents
Dosage and Administration for Investigational material
Sponsors
AstraZeneca
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Patients who have signed this Written Informed Consent Form after a full explanation about the participation in this study - Patients aged 18 years or older Patients diagnosed with a solid malignant tumour or malignant lymphoma that is refractory to standard therapies or for which no standard therapies exist - Patients with good physical conditions (you can walk and can look after yourself) within the last 2 weeks. - Patients who have at least one lesion that can be accurately assessed
Exclusion criteria
Exclusion criteria: - Patients who have recently received or are receiving prohibited medications or treatments - Patients who have any unresolved side effects of previous treatments - Patients who have spinal cord compression or brain metastases - Patients who have severe systemic diseases (e.g., uncontrolled hypertension, hepatitis B, hepatitis C and human immunodeficiency virus [HIV] infection) - Patients with significant abnormal ECG findings
Outcome results
None listed